PAIN THERAPEUTICS WKN: A2PGL8 ISIN: US14817C1071 Kürzel: SAVA Forum: Aktien Thema: Hauptdiskussion

So was gabs doch schob mal ohne dass wirklich informativ was bei rum kam soweit ich mich erinnere...

https://www.cassavasciences.com/news-releases/news-release-details/cassava-sciences-present-hc-wainwright-global-investment

Remi Barbier, President & CEO, will participate in-person at this corporate event. Institutional investors who are registered for this conference may log into www.hcwevents.com to request a meeting with Cassava Sciences, pending availability. Event details follow: Date: Tuesday, September 13th Time: 3:30pm to 4:00 Eastern Time Webcast: https://journey.ct.events/view/ffcd827b-9de0-4b05-a6fd-5ea79810a3ee A live webcast will be available on the “Investors” page of Cassava Sciences’ website, www.CassavaSciences.com. An archived replay will be available for 90 days following the event. About Cassava Sciences, Inc. Cassava Sciences Inc. is a clinical stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer's disease. Our novel science is based on stabilizing – but not removing – a critical protein in the brain. We are currently testing simufilam, our lead drug candidate for the proposed treatment of Alzheimer's disease dementia, in a large Phase 3 clinical program under Special Protocol Assessments from the FDA.

Aha.😃

Und wann soll dieses "demnächst" sein?

Insider wissen immer mehr wie aussen stehende

Welche?

bzw. worin liegt der Optimismus begründet

Und welche

News gibt es dem nächst 😊

Das ist doch wunderbar:)

Gibt's denn irgendwie News?

Weiter weiter , so macht das Spaß

News oder einfach nur Spaß an der Freude?

Was ein Angriff

Danke, jetzt bin ich wieder auf dem neusten Stand.